Trial: 202111065

A Phase 1/2, Single-arm Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of Avapritinib in Pediatric Patients with Solid Tumors Dependent on KIT or PDGFRA Signaling



Principal Investigator

Abdelbaki, Mohamed

Disease Site

Bones and Joints; Brain and Nervous System; Other Male Genital; Soft Tissue

Learn more about this study at: